Abstract
The management of type 2 diabetes requires multifactorial approach in terms of diet, lifestyle modification and pharmacological treatment to prevent or delay complications and maintain the quality of life. Several studies have been conducted to enhance the treatment of type 2 diabetes. However, there was a lack of data regarding the prescription pattern of antidiabetics among clinicians. So, a cross-sectional, questionnaire based study was conducted to gather information about the prevalence, risk factors, and management of diabetes within a population. The data was collected from 551 doctors across all over India. About 44% doctors reported that 5-10 patients per week were newly diagnosed with type 2 diabetes. In this study, 66% of the doctors reported cardiovascular events as a major complication and 28% of the doctors reported renal complications in uncontrolled type 2 diabetes patients. 48% of the 551 clinicians used DPP4 inhibitors as an add on, followed by 30% who reported the use of SGLT2 inhibitors. Notably, 92% of the participants reported urinary tract infection as the most common undesirable effect in their patients, with the usage of dapagliflozin. Nearly 30% of the clinicians in our survey have prescribed SGLT2 inhibitors for patients who are at >50% risk of developing chronic kidney disease. The results from our study, stated that most of the clinicians use DPP4 inhibitors and SGLT2 inhibitors as an add on to metformin in patients with a failure to control the glycaemic index. Dapagliflozin is prescribed not only to control the glycaemic index but also to reduce the hospitalization due to heart failure and other cardiovascular and renal co-morbidities.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.